I-VADE Overview
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$638K
- Investors
-
2
I-VADE General Information
Description
Developer of immersive training technology designed for healthcare aggression de-escalation training. The company's platform uses virtual reality simulations with dynamic, AI-driven patient interactions and motion-captured behaviours, enabling healthcare workers to practice situational responses in a controlled environment that adjusts to user empathy and communication, enhancing preparedness for real-world hostile encounters through scalable, repeatable, and context-rich training experiences.
Contact Information
Corporate Office
- Canberra, Australian Capital Territory
- Australia
Corporate Office
- Canberra, Australian Capital Territory
- Australia
I-VADE Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | $638K | Completed | Startup | |||
| 1. Accelerator/Incubator | 10-Apr-2025 | Completed | Startup |
I-VADE Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CSIRO ON Accelerate | Accelerator/Incubator | |||
| WA Health, Government of Western Australia | Government |
I-VADE FAQs
-
Where is I-VADE headquartered?
I-VADE is headquartered in Canberra, Australia.
-
What industry is I-VADE in?
I-VADE’s primary industry is Other Healthcare Technology Systems.
-
Is I-VADE a private or public company?
I-VADE is a Private company.
-
What is I-VADE’s current revenue?
The current revenue for I-VADE is .
-
Who are I-VADE’s investors?
CSIRO ON Accelerate and WA Health, Government of Western Australia have invested in I-VADE.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process